Diagnos Laboratorium Utama Tbk. vs Soraya Berjaya Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Soraya Berjaya Indonesia Tbk. trades at Rp83 (market cap 60.8B, 760.3K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 5.1× Soraya Berjaya Indonesia Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 760.3K). Which is the better fit depends on your goals.
| DGNS | SPRE | |
|---|---|---|
Market Cap | 310.75B | 60.8B |
Volume | 963.6K | 760.3K |
Lot | 9.64K | 7.6K |
Turnover | 217.67M | 62.04M |
Average Price | 225.89 | 81.6 |
Value | 217.67M | 62.04M |
Indicative Equilibrium Price | 226 | 83 |
Indicative Equilibrium Volume | 1K | 17 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT. Soraya Berjaya Indonesia (Company) was established based on Deed No. 05 dated March 05, 2015 by Notary Martalena, S.H., in Padang. Perseroan memulai kegiatan komersilnya pada tahun 2015. dengan mengoperasikan menggunakan merek dagang Soraya Bed Sheet.
Read more on SPRE →